Oral peptide therapeutics for diabetes treatment: State-of-the-art and future perspectives

• Main Authors: Bingwen Ding (Author), Zhu Zhu (Author), Cong Guo (Author), Jiaxin Li (Author), Yong Gan (Author), Miaorong Yu (Author)
• Format: Book
• Published: Elsevier, 2024-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Diabetes, characterized by hyperglycemia, is a major cause of death and disability worldwide. Peptides, such as insulin and glucagon-like peptide-1 (GLP-1) analogs, have shown promise as treatments for diabetes due to their ability to mimic or enhance insulin's actions in the body. Compared to...